About
About
Ignition Scientific builds tools and advises on translating large molecular datasets into diagnostics and therapeutics. We work in population multi-omics, diagnostic translation, and precision medicine, partnering with academic labs, technology providers, and biotech companies to move discoveries from early data toward real clinical tests. Ignition was founded by Chris Whelan, Ph.D. - co-founder and former lead of the UK Biobank Pharma Proteomics Project - and brings the translational infrastructure, IP strategy, and delivery needed to take discoveries from the lab toward clinical use.
Ignition Scientific builds tools and advises on translating large molecular datasets into diagnostics and therapeutics. We work in population multi-omics, diagnostic translation, and precision medicine, partnering with academic labs, technology providers, and biotech companies to move discoveries from early data toward real clinical tests. Ignition was founded by Chris Whelan, Ph.D. - co-founder and former lead of the UK Biobank Pharma Proteomics Project - and brings the translational infrastructure, IP strategy, and delivery needed to take discoveries from the lab toward clinical use.
Want to work with us?
Want to work with us?
As part of previous initiatives, we have united some of the world’s leading pharmaceutical companies & most prestigious academic institutions. A selection of these partners is listed above (please note that their logos do not constitute formal endorsements of Ignition Scientific). If you have a potential proteomic stratification tool but need help translating to the clinic, or finding the right collaborators, we’d love to hear from you.
As part of previous initiatives, we have united some of the world’s leading pharmaceutical companies & most prestigious academic institutions. A selection of these partners is listed above (please note that their logos do not constitute formal endorsements of Ignition Scientific). If you have a potential proteomic stratification tool but need help translating to the clinic, or finding the right collaborators, we’d love to hear from you.